Director exercised or converted 7,304 HALO derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 29, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 30, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001159036-26-000082
Filed / recordedJun 30, 2026, 9:25 PM UTCAdded to OQROOct 6, 2026, 7:59 PM UTC Data qualityVerified: identifiers matched exactly IssuerHALOZYME THERAPEUTICS, INC. Reporting personMahesh Krishnan SecurityOption to Purchase Common Stock TableDerivative (Table II) Transaction dateJun 29, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Grant to Reporting Person of options exercisable as of April 25, 2025.